Michael on for Puneet Souda's questions to Twist Bioscience Corp (TWST) leadership • Q3 2025
Question
Representing Puneet Souda, Michael asked about the drivers of the 10% sequential growth in the U.S. academic market, questioning whether it was due to share gains or an unexpectedly strong end market.
Answer
President & COO Dr. Patrick Finn attributed the growth to Twist's compelling value proposition, which allows customers to get 'more shots on goal' for the same budget, driving market share gains in a challenging funding environment. CFO Adam Laponis clarified that the 10% growth figure was for sequential, not year-over-year, growth.